Search
Tetracosactide
go.drugbank.com/drugs/DB01284ApprovedInvestigationalACTH (1-24), a segment similar in all species, contains the biological activity that stimulates production of corticosteroids in the adrenal cortex. … The complex results in a product whose absorption in man is effected over a longer period of time as compared to corticotropin. Therefore, therapy may be maintained with less frequent administration.
Products: Cortrosyn Inj 0.25mgTapentadol
go.drugbank.com/drugs/DB06204ApprovedInvestigational[L47291] Used in the management of pain, tapentadol is typically reserved for patients who have limited alternative treatment options. … Tapentadol is a centrally-acting synthetic analgesic with a dual mechanism of action. It is a mu-opioid receptor agonist that also inhibits norepinephrine reuptake.
Products: Nucynta Ir, Nucynta IR Tablets 50 mgDiazoxide
go.drugbank.com/drugs/DB01119ApprovedInvestigationalIn September 2015, the FDA issued a safety alert regarding post-marketing reports of pulmonary hypertension occurring in infants and neonates. … [A255647,L44612] In March 2025, an extended-release formulation of diazoxide choline was approved by the FDA for the treatment of hyperphagia in patients with Prader-Willi syndrome, becoming the first
Categories: Arteriolar Smooth Muscle, Agents Acting OnProducts: Hyperstat Inj 15mg/mlChloroxylenol
go.drugbank.com/drugs/DB11121ApprovedIt is found in antibacterial soaps, wound-cleansing applications, and household antiseptics. … Chloroxylenol is on the World Health Organization's List of Essential Medicines.
Mixtures: Multi-action Denorex 2-IN-1 Dandruff Shampoo + ConditionerCategories: Compounds used in a research, industrial, or household settingRelapsed Chronic Lymphocytic Leukemia
go.drugbank.com/conditions/DBCOND0060745Synonyms: Chronic Lymphoid Leukemia in Relapse, Chronic lymphoid leukemia in relapse (disorder)Obinutuzumab
go.drugbank.com/drugs/DB08935ApprovedInvestigational[L54521] Like other drugs in its class, obinutuzumab targets the CD20 antigen expressed on the surface of pre-B and mature B lymphocytes, mediating B-cell lysis. … [L54521] It was developed as a Type II anti-CD20 antibody to improve upon first-generation agents like rituximab.
Products: GAZYVA 1000 MG IV İNFÜZYONLUK KONSANTRE ÇÖZELTİ, 1 ADETGatifloxacin
go.drugbank.com/drugs/DB01044ApprovedInvestigationalWithdrawnGatifloxacin is available as tablets and in various aqueous solutions for intravenous therapy. It is also available as eye drops under the brand name Zymar® marketed by Allergan. … It was first introduced by Bristol-Myers Squibb in 1999 under the brand name Tequin® for the treatment of respiratory tract infections.
Categories: Compounds used in a research, industrial, or household setting, Topoisomerase II InhibitorsProducts: Tequin IVCefotetan
go.drugbank.com/drugs/DB01330ApprovedInvestigationalThe drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms. … A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly.
Products: Cefotan Inj 2gm/vialBudesonide
go.drugbank.com/drugs/DB01222ApprovedInvestigational[A188529,A188532] Budesonide was granted FDA approval on 14 February 1994.[L10598] It is also available in a combination product with [formoterol].[L10619] … Budesonide is a glucocorticoid that is a mix of the 22R and 22S epimer used to treat inflammatory conditions of the lungs and intestines such as asthma, COPD, Crohn's disease, and ulcerative colitis.
Products: PULMICORT RESPULES (1 MG IN 2 ML), PULMICORT RESPULES (0.5 MG IN 2 ML)